Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Revenue (2022 - 2026)

Envoy Medical's Revenue history spans 5 years, with the latest figure at $39000.0 for Q1 2026.

  • On a quarterly basis, Revenue fell 15.22% to $39000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $234000.0, a 10.38% increase, with the full-year FY2025 number at $241000.0, up 7.11% from a year prior.
  • Revenue hit $39000.0 in Q1 2026 for Envoy Medical, down from $75000.0 in the prior quarter.
  • Over the last five years, Revenue for COCH hit a ceiling of $95000.0 in Q4 2023 and a floor of $20000.0 in Q4 2022.
  • Historically, Revenue has averaged $59866.7 across 5 years, with a median of $59000.0 in 2024.
  • Biggest five-year swings in Revenue: skyrocketed 375.0% in 2023 and later tumbled 55.79% in 2024.
  • Tracing COCH's Revenue over 5 years: stood at $20000.0 in 2022, then skyrocketed by 375.0% to $95000.0 in 2023, then tumbled by 55.79% to $42000.0 in 2024, then surged by 78.57% to $75000.0 in 2025, then plummeted by 48.0% to $39000.0 in 2026.
  • Business Quant data shows Revenue for COCH at $39000.0 in Q1 2026, $75000.0 in Q4 2025, and $42000.0 in Q3 2025.